Wyvern Pharmaceuticals Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- August 1, 2018 – February 28, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q2-912219
Published purpose
The ability of Wyvern DR to down regulate or reduce the expression of multiple checkpoint molecules in human lung epithelium will be investigated.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions